Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
Whatever we may think individually about the recent decision by the U.S. Preventive Services Task Force to recommend against the use of PSA testing as a means of “screening” for risk of prostate cancer, we would be wise to understand that at the heart of this decision is poor science.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: PSA, risk, screening, survival, USPSTF | 29 Comments »
The U.S. Preventive Services Task Force (USPSTF) — after previously stating that it would be releasing its new recommendations about PSA testing for risk of prostate cancer on Tuesday next week — has been pressured (by a variety of organizations, and by the media) to release its draft recommendation today.
Filed under: Diagnosis, Risk | Tagged: Diagnosis, PSA, risk, testing, USPSTF | 14 Comments »
A new article by Dr. Howard Scher of Memorial Sloan-Kettering Cancer Center on the OncologySTAT web site discusses recent developments in the application of levels of circulating tumor cells (CTCs) in clinical practice and in the assessment of outcomes in clinical trials.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: circulating tumor cells, CTCs | Leave a Comment »
A videotaped expert commentary by Dr. Johann de Bono on the Medscape Oncology web site (with transcript) discusses four therapies (three now approved in the USA) that have recently demonstrated a survival benefit in the treatment of metastatic, castration-resistant prostate cancer.
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: abiraterone acetate, cabazitaxel, radium-223, sipuleucel-T | Leave a Comment »
According to an article in today’s New York Times, the United States Preventive Services Task Force (USPSTF) has chosen to advise against routine use of the PSA test to screen healthy men for prostate cancer because “the test does not save lives and often leads to more tests and treatments that needlessly cause pain, impotence [...]
Filed under: Diagnosis, Risk | Tagged: Diagnosis, risk, screening | 10 Comments »
According to a report presented today at the annual meeting of the American Society for Radiation Oncology (ASTRO) in Miami Beach, Florida, men with localized prostate cancer who were treated 15 years ago with external beam radiation therapy had no significant survival benefit compared to men followed with watchful waiting.
Filed under: Management, Treatment | Tagged: comparison, outcome, radiation therapy, watchful waiting | Leave a Comment »
An article in the New York Times magazine, just published on the New York Times web site, takes on the debate we have all been involved in from different points of view for most of the past 20 years. People have passionate beliefs on this subject. We will just refer you to the article.
Filed under: Uncategorized | 6 Comments »
Many readers of The “New” Prostate Cancer InfoLink may be interested in listening to or reading the transcript of a program on Science Friday on National Public Radio that aired last Monday.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: radical prostatectomy, sex, sexual function, Treatment | 1 Comment »
A population-based analysis of mortality data for men diagnosed with prostate cancer from three European nations suggests that “a small but important group of older patients” initially present with late stage prostate cancer and die rapidly as a consequence.
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: Diagnosis, elderly, mortality, stage, survival | 11 Comments »
A review article on issues affecting perceptions of prostate cancer among Black men of African, Afro-Caribbean, and African American ethnicity has highlit the very limited data available about prostate cancer, its diagnosis, and its management in males from specific ethnic groups inside and outside the USA.
Filed under: Diagnosis, Management, Risk | Tagged: Australia, black, ethnicity, indigenous, native American | Leave a Comment »
A multi-institutional “Registry for Prostate Cancer Radiosurgery” (RPCR) was initially set up in July 2010 to track clinical and functional outcomes of men with localized prostate cancer treated with the CyberKnife stereotactic body radiation therapy system (SBRT) at academic and community-based centers throughout the U.S.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: CyberKnife, outcome, registry, stereotactic body radiation therapy | 3 Comments »
The SELECT study has previously shown that treatment with selenium did not prevent prostate cancer in your average “guy in the street.” However, what about men with a prior diagnosis of high-grade prostatic intraepithelial neoplasia (HG-PIN)?
Filed under: Diagnosis, Management, Prevention, Risk | Tagged: HG-PIN, prostatic intraepithelial neoplasia, selenium, trial | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site